NEW YORK, May 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
http://www.reportlinker.com/p0511068/Drug-Delivery-Devices-Market-Outlook-in-United-States-to-2017---Metered-Dose-Inhaler-Devices-Infusion-Systems-Central-Venous-Catheters-and-Needle-Free-Injections.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Summary
GlobalData's new report, "Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the United States Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the United States Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, Hospira, Inc., CareFusion Corporation, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc. and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United States Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What is This Report About? 12
3 Drug Delivery Devices In United States 13
3.1 Drug Delivery Devices, Market Segmentation 13
3.2 Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 14
3.3 Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010 16
3.4 Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17
3.5 Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23
3.6 Drug Delivery Devices, United States, Company Share (2009-2010) 28
4 Central Venous Catheters In United States 30
4.1 Central Venous Catheters, Market Segmentation 30
4.2 Central Venous Catheters Market, United States, Revenue Mix ($m), 2010 31
4.3 Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32
4.4 Central Venous Catheters Overall Revenue (2003-2017) 33
4.5 Central Venous Catheters Overall Volume (2003-2017) 37
4.6 Central Venous Catheters Average Price (2003-2017) 41
4.7 Central Venous Catheters Distribution Share (2009-2010) 42
4.8 Central Venous Catheters, United States, Company Share (2009-2010) 43
5 Infusion Systems In United States 45
5.1 Infusion Systems, Market Segmentation 45
5.2 Infusion Systems Market, United States, Revenue Mix ($m), 2010 46
5.3 Infusion Systems Market, United States, Segment Contribution (%), 2010 47
5.4 Infusion Systems Overall Revenue (2003-2017) 48
5.4.1 Syringe Pumps Revenue (2003-2010) 52
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2010) 56
5.5 Infusion Systems Overall Volume (2003-2017) 60
5.5.1 Syringe Pumps Volume (2003-2010) 64
5.5.2 Ambulatory Infusion Pumps Volume (2003-2010) 66
5.6 Infusion Systems Average Price (2003-2017) 70
5.7 Infusion Systems Distribution Share (2009-2010) 71
5.8 Infusion Systems, United States, Company Share (2009-2010) 72
6 Metered Dose Inhaler Devices In United States 74
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 74
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 76
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 78
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 79
6.5 Metered Dose Inhaler Devices, United States, Company Share (2009-2010) 80
7 Needle Free Injections In United States 82
7.1 Needle Free Injections Overall Revenue (2003-2017) 82
7.2 Needle Free Injections Overall Volume (2003-2017) 84
7.3 Needle Free Injections Average Price (2003-2017) 86
7.4 Needle Free Injections Distribution Share (2009-2010) 87
7.5 Needle Free Injections, United States, Company Share (2009-2010) 88
8 Overview of Key Companies in United States Drug Delivery Devices Market 90
8.1 GlaxoSmithKline plc 90
8.1.1 Company Overview 90
8.1.2 Share in the United States Drug Delivery Devices Market 90
8.2 Hospira, Inc. 91
8.2.1 Company Overview 91
8.2.2 Share in the United States Drug Delivery Devices Market 91
8.3 CareFusion Corporation 92
8.3.1 Company Overview 92
8.3.2 Share in the United States Drug Delivery Devices Market 92
8.4 Boehringer Ingelheim GmbH 93
8.4.1 Company Overview 93
8.4.2 Share in the United States Drug Delivery Devices Market 93
8.5 AstraZeneca PLC 94
8.5.1 Company Overview 94
8.5.2 Share in the United States Drug Delivery Devices Market 94
8.6 Baxter International Inc. 95
8.6.1 Company Overview 95
8.6.2 Share in the United States Drug Delivery Devices Market 95
8.7 Medtronic, Inc. 96
8.7.1 Company Overview 96
8.8 Teleflex Incorporated 96
8.8.1 Company Overview 96
8.9 Smiths Medical 97
8.9.1 Company Overview 97
8.10 Fresenius Kabi AG 97
8.10.1 Company Overview 97
8.11 B. Braun Melsungen AG 97
8.11.1 Company Overview 97
8.12 Terumo Corporation 98
8.12.1 Company Overview 98
8.13 Consort Medical plc 98
8.13.1 Company Overview 98
8.14 3M Health Care 98
8.14.1 Company Overview 98
8.15 Edwards Lifesciences Corporation 99
8.15.1 Company Overview 99
8.16 Becton, Dickinson and Company 99
8.16.1 Company Overview 99
8.17 Cook Medical Incorporated 99
8.17.1 Company Overview 99
8.18 INJEX - Equidyne Systems 100
8.18.1 Company Overview 100
8.19 Antares Pharma, Inc. 100
8.19.1 Company Overview 100
8.20 Bioject Medical Technologies Inc. 100
8.20.1 Company Overview 100
9 Drug Delivery Devices Market Pipeline Products 101
10 Financial Deals Landscape 108
10.1 Acquisition 108
10.1.1 CarePoint Partners Acquires Premier Infusion 108
10.1.2 SurModics Plans The Sale Of SurModics Pharmaceuticals 109
10.1.3 BTG International To Acquire Biocompatibles 110
10.1.4 Nordson Completes Acquisition Of Micromedics 112
10.1.5 Cardinal Health Sells 13.7% Stake In Carefusion 113
10.1.6 Cellectis Acquires Cyto Pulse Sciences 114
10.2 Partnerships 115
10.2.1 Eli Lilly Enters Into Collaboration With Medtronic 115
10.2.2 West Pharmaceutical Enters Into Agreement With CareFusion 116
10.2.3 Nile Therapeutics Enters Into An Agreement With Medtronic 117
10.2.4 Hospira Enters Into An Agreement With Smiths Medical 118
10.2.5 AorTech International Enters Into Technology License Agreement 119
11 Recent Developments 120
11.1 Strategy and Business Planning 120
11.1.1 Nov 01, 2010: HepaLife Launches Alliqua To Focus On Development, Manufacturing And Marketing Of Proprietary Transdermal Drug Delivery Products 120
11.1.2 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units 121
11.1.3 Aug 31, 2010: Vetter Opens New Sales Office At Illinois Science + Technology Park In Suburban Chicago 122
11.1.4 Aug 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey 122
11.1.5 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring 123
11.1.6 Jul 14, 2010: GE Healthcare To Shut Down Two Offices In Waukesha 123
11.1.7 Jul 01, 2010: Shionogi Announces Reorganization Of US Operations 123
11.1.8 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 124
11.2 Legal and Regulatory 124
11.2.1 Mar 16, 2011: Tekmira Sues Alnylam Pharmaceuticals For Repeated Misuse Of Trade Secrets And Confidential Information 124
11.2.2 Feb 11, 2011: University Of Florida Research Foundation Initiates Court Case Against Diamyd Medical 125
11.2.3 Nov 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter 125
11.2.4 Nov 09, 2010: Greenberg Traurig And Segal McCambridge Singer & MahoneyObtain Three Defense Verdicts For I-Flow In Oregon Infusion Pump Cases 126
11.2.5 Nov 03, 2010: Protein Sciences Reports Settlement With Emergent BioSolutions 126
11.2.6 Sep 03, 2010: BioSphere Agrees To Settle Suit Over Merit Medical merger 126
11.2.7 Jul 30, 2010: Federal Appeals Court Rules In Favor Of Covidien In Needle Patents Suit 126
11.2.8 Jul 23, 2010: BioSphere Names In Class Action By Shareholders: SEC Filing 127
11.2.9 Jun 10, 2010: I-Flow Resolves Patent Infringement, Trade Secret Litigation Against Apex Medical Technologies, Zone Medical 127
11.3 Government and Public Interest 127
11.3.1 Mar 16, 2011: Syracuse University Scientists Develop New Drug Delivery System To Improve Cancer Treatment 127
11.3.2 Feb 17, 2011: Delcath Achieves ISO 13485 Certification 128
11.3.3 Dec 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design 129
11.3.4 Oct 26, 2010: GERES Study Confirms Passive Safety Devices Are Most Effective In Needlestick Injury Prevention 129
11.3.5 Aug 31, 2010: Purdue University Researchers Develop New Pump For Microneedle Drug-Delivery Patch 130
11.3.6 Aug 09, 2010: Talecris Biotherapeutics And Grifols Receive FTC Request For Additional Information Regarding Proposed Merger 131
11.3.7 Jun 14, 2010: Electronic Cigarettes Are Drug Delivery Devices And Should Be Subject To FDA Regulations: AMA 132
11.4 Product News 132
11.4.1 Jul 27, 2010: Dentistry Today Selects Milestone's STA Single Tooth Anesthesia System For Top 100 Products Award Program 132
11.4.2 Jul 13, 2010: Baxter Announces Final Details Regarding Previously Communicated COLLEAGUE Infusion Pump Recall In US 133
11.4.3 Jul 08, 2010: Bioject Announces Use Of Its Intradermal Needle-Free Delivery System In World Health Organization Clinical Trial In Oman With Poliovirus Vaccine 134
12 Appendix 135
12.1 Definitions of Markets Covered in the Report 136
12.1.1 Drug Delivery Devices 136
12.2 Research Methodology 138
12.3 Secondary Research 139
12.4 Primary Research 139
12.5 Models 140
12.6 Forecasts 140
12.7 Expert Panels 140
12.8 GlobalData Consulting 140
12.9 Currency Conversion 141
12.10 Contact Us 141
12.11 Disclaimer 141
1.1 List of Tables
Table 1: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 15
Table 2: Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17
Table 3: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017 18
Table 4: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010 20
Table 5: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 22
Table 6: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23
Table 7: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010 25
Table 8: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017 27
Table 9: Drug Delivery Devices, United States, Company Share by Revenue ($m), 2009-2010 29
Table 10: Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32
Table 11: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010 34
Table 12: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017 36
Table 13: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010 38
Table 14: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017 40
Table 15: Central Venous Catheters, United States, Average Price ($), Historic, 2003-2010 41
Table 16: Central Venous Catheters, United States, Average Price ($), Forecast, 2010-2017 41
Table 17: Central Venous Catheters, United States, Distribution Share by Revenue ($m), 2009-2010 42
Table 18: Central Venous Catheters, United States, Company Share by Revenue ($m), 2009-2010 44
Table 19: Infusion Systems Market, United States, Segment Contribution (%), 2010 47
Table 20: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010 49
Table 21: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017 51
Table 22: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 53
Table 23: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 55
Table 24: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 57
Table 25: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 59
Table 26: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010 61
Table 27: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017 63
Table 28: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Table 29: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Table 30: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Table 31: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Table 32: Infusion Systems, United States, Average Price ($), Historic, 2003-2010 70
Table 33: Infusion Systems, United States, Average Price ($), Forecast, 2010-2017 70
Table 34: Infusion Systems, United States, Distribution Share by Revenue ($m), 2009-2010 71
Table 35: Infusion Systems, United States, Company Share by Revenue ($m), 2009-2010 73
Table 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010 74
Table 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017 75
Table 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010 76
Table 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017 77
Table 40: Metered Dose Inhaler Devices, United States, Average Price ($), Historic, 2003-2010 78
Table 41: Metered Dose Inhaler Devices, United States, Average Price ($), Forecast, 2010-2017 78
Table 42: Metered Dose Inhaler Devices, United States, Distribution Share by Revenue ($m), 2009-2010 79
Table 43: Metered Dose Inhaler Devices, United States, Company Share by Revenue ($m), 2009-2010 81
Table 44: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010 82
Table 45: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017 83
Table 46: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010 84
Table 47: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017 85
Table 48: Needle Free Injections, United States, Average Price ($), Historic, 2003-2010 86
Table 49: Needle Free Injections, United States, Average Price ($), Forecast, 2010-2017 86
Table 50: Needle Free Injections, United States, Distribution Share by Revenue ($m), 2009-2010 87
Table 51: Needle Free Injections, United States, Company Share by Revenue ($m), 2009-2010 89
Table 52: Drug Delivery Devices Market Pipeline Products 101
Table 53: CarePoint Partners Acquires Premier Infusion 108
Table 54: SurModics Plans The Sale Of SurModics Pharmaceuticals 109
Table 55: BTG International To Acquire Biocompatibles 110
Table 56: Nordson Completes Acquisition Of Micromedics 112
Table 57: Cardinal Health Sells 13.7% Stake In Carefusion 113
Table 58: Cellectis Acquires Cyto Pulse Sciences 114
Table 59: Eli Lilly Enters Into Collaboration With Medtronic 115
Table 60: West Pharmaceutical Enters Into Agreement With CareFusion 116
Table 61: Nile Therapeutics Enters Into An Agreement With Medtronic 117
Table 62: Hospira Enters Into An Agreement With Smiths Medical 118
Table 63: AorTech International Enters Into Technology License Agreement 119
Table 64: USD to Local Currency, United States, Average Actual Rate 2003-2010 141
1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 13
Figure 2: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 14
Figure 3: Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010 16
Figure 4: Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17
Figure 5: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017 18
Figure 6: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010 19
Figure 7: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 21
Figure 8: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23
Figure 9: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010 24
Figure 10: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017 26
Figure 11: Drug Delivery Devices, United States, Company Share (%), 2010 28
Figure 12: Central Venous Catheters, Market Segmentation 30
Figure 13: Central Venous Catheters Market, United States, Revenue Mix ($m), 2010 31
Figure 14: Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32
Figure 15: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010 33
Figure 16: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017 35
Figure 17: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010 37
Figure 18: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017 39
Figure 19: Central Venous Catheters, United States, Company Share (%), 2010 43
Figure 20: Infusion Systems, Market Segmentation 45
Figure 21: Infusion Systems Market, United States, Revenue Mix ($m), 2010 46
Figure 22: Infusion Systems Market, United States, Segment Contribution (%), 2010 47
Figure 23: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010 48
Figure 24: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017 50
Figure 25: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52
Figure 26: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54
Figure 27: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Figure 28: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Figure 29: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010 60
Figure 30: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017 62
Figure 31: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Figure 32: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Figure 33: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Figure 34: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 35: Infusion Systems, United States, Company Share (%), 2010 72
Figure 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010 74
Figure 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017 75
Figure 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010 76
Figure 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017 77
Figure 40: Metered Dose Inhaler Devices, United States, Company Share (%), 2010 80
Figure 41: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010 82
Figure 42: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017 83
Figure 43: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010 84
Figure 44: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017 85
Figure 45: Needle Free Injections, United States, Company Share (%), 2010 88
Figure 46: GlaxoSmithKline plc, Company Share (%),United States Drug Delivery Devices Market, 2010 90
Figure 47: Hospira, Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 91
Figure 48: CareFusion Corporation, Company Share (%),United States Drug Delivery Devices Market, 2010 92
Figure 49: Boehringer Ingelheim GmbH, Company Share (%),United States Drug Delivery Devices Market, 2010 93
Figure 50: AstraZeneca PLC, Company Share (%),United States Drug Delivery Devices Market, 2010 94
Figure 51: Baxter International Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 95
Companies MentionedGlaxoSmithKline plc
Hospira, Inc.
CareFusion Corporation
Boehringer Ingelheim GmbH
AstraZeneca PLC
Baxter International Inc.
Medtronic, Inc.
Teleflex Incorporated
Smiths Medical
Fresenius Kabi AG
B. Braun Melsungen AG
Terumo Corporation
Consort Medical plc
3M Health Care
Edwards Lifesciences Corporation
Becton, Dickinson and Company
Cook Medical Incorporated
INJEX - Equidyne Systems
Antares Pharma, Inc.
Bioject Medical Technologies Inc.
To order this report:
Drug Delivery Technology Industry: Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Drug Delivery Technology Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
CONTACTNicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
Advertisement
Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Advertisement
http://www.reportlinker.com/p0511068/Drug-Delivery-Devices-Market-Outlook-in-United-States-to-2017---Metered-Dose-Inhaler-Devices-Infusion-Systems-Central-Venous-Catheters-and-Needle-Free-Injections.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Summary
GlobalData's new report, "Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the United States Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the United States Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, Hospira, Inc., CareFusion Corporation, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc. and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United States Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What is This Report About? 12
3 Drug Delivery Devices In United States 13
3.1 Drug Delivery Devices, Market Segmentation 13
3.2 Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 14
3.3 Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010 16
3.4 Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17
3.5 Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23
3.6 Drug Delivery Devices, United States, Company Share (2009-2010) 28
4 Central Venous Catheters In United States 30
4.1 Central Venous Catheters, Market Segmentation 30
4.2 Central Venous Catheters Market, United States, Revenue Mix ($m), 2010 31
4.3 Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32
4.4 Central Venous Catheters Overall Revenue (2003-2017) 33
4.5 Central Venous Catheters Overall Volume (2003-2017) 37
4.6 Central Venous Catheters Average Price (2003-2017) 41
4.7 Central Venous Catheters Distribution Share (2009-2010) 42
4.8 Central Venous Catheters, United States, Company Share (2009-2010) 43
5 Infusion Systems In United States 45
5.1 Infusion Systems, Market Segmentation 45
5.2 Infusion Systems Market, United States, Revenue Mix ($m), 2010 46
5.3 Infusion Systems Market, United States, Segment Contribution (%), 2010 47
5.4 Infusion Systems Overall Revenue (2003-2017) 48
5.4.1 Syringe Pumps Revenue (2003-2010) 52
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2010) 56
5.5 Infusion Systems Overall Volume (2003-2017) 60
5.5.1 Syringe Pumps Volume (2003-2010) 64
5.5.2 Ambulatory Infusion Pumps Volume (2003-2010) 66
5.6 Infusion Systems Average Price (2003-2017) 70
5.7 Infusion Systems Distribution Share (2009-2010) 71
5.8 Infusion Systems, United States, Company Share (2009-2010) 72
6 Metered Dose Inhaler Devices In United States 74
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 74
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 76
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 78
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 79
6.5 Metered Dose Inhaler Devices, United States, Company Share (2009-2010) 80
7 Needle Free Injections In United States 82
7.1 Needle Free Injections Overall Revenue (2003-2017) 82
7.2 Needle Free Injections Overall Volume (2003-2017) 84
7.3 Needle Free Injections Average Price (2003-2017) 86
7.4 Needle Free Injections Distribution Share (2009-2010) 87
7.5 Needle Free Injections, United States, Company Share (2009-2010) 88
8 Overview of Key Companies in United States Drug Delivery Devices Market 90
8.1 GlaxoSmithKline plc 90
8.1.1 Company Overview 90
8.1.2 Share in the United States Drug Delivery Devices Market 90
8.2 Hospira, Inc. 91
8.2.1 Company Overview 91
8.2.2 Share in the United States Drug Delivery Devices Market 91
8.3 CareFusion Corporation 92
8.3.1 Company Overview 92
8.3.2 Share in the United States Drug Delivery Devices Market 92
8.4 Boehringer Ingelheim GmbH 93
8.4.1 Company Overview 93
8.4.2 Share in the United States Drug Delivery Devices Market 93
8.5 AstraZeneca PLC 94
8.5.1 Company Overview 94
8.5.2 Share in the United States Drug Delivery Devices Market 94
8.6 Baxter International Inc. 95
8.6.1 Company Overview 95
8.6.2 Share in the United States Drug Delivery Devices Market 95
8.7 Medtronic, Inc. 96
8.7.1 Company Overview 96
8.8 Teleflex Incorporated 96
8.8.1 Company Overview 96
8.9 Smiths Medical 97
8.9.1 Company Overview 97
8.10 Fresenius Kabi AG 97
8.10.1 Company Overview 97
8.11 B. Braun Melsungen AG 97
8.11.1 Company Overview 97
8.12 Terumo Corporation 98
8.12.1 Company Overview 98
8.13 Consort Medical plc 98
8.13.1 Company Overview 98
8.14 3M Health Care 98
8.14.1 Company Overview 98
8.15 Edwards Lifesciences Corporation 99
8.15.1 Company Overview 99
8.16 Becton, Dickinson and Company 99
8.16.1 Company Overview 99
8.17 Cook Medical Incorporated 99
8.17.1 Company Overview 99
8.18 INJEX - Equidyne Systems 100
8.18.1 Company Overview 100
8.19 Antares Pharma, Inc. 100
8.19.1 Company Overview 100
8.20 Bioject Medical Technologies Inc. 100
8.20.1 Company Overview 100
9 Drug Delivery Devices Market Pipeline Products 101
10 Financial Deals Landscape 108
10.1 Acquisition 108
10.1.1 CarePoint Partners Acquires Premier Infusion 108
10.1.2 SurModics Plans The Sale Of SurModics Pharmaceuticals 109
10.1.3 BTG International To Acquire Biocompatibles 110
10.1.4 Nordson Completes Acquisition Of Micromedics 112
10.1.5 Cardinal Health Sells 13.7% Stake In Carefusion 113
10.1.6 Cellectis Acquires Cyto Pulse Sciences 114
10.2 Partnerships 115
10.2.1 Eli Lilly Enters Into Collaboration With Medtronic 115
10.2.2 West Pharmaceutical Enters Into Agreement With CareFusion 116
10.2.3 Nile Therapeutics Enters Into An Agreement With Medtronic 117
10.2.4 Hospira Enters Into An Agreement With Smiths Medical 118
10.2.5 AorTech International Enters Into Technology License Agreement 119
11 Recent Developments 120
11.1 Strategy and Business Planning 120
11.1.1 Nov 01, 2010: HepaLife Launches Alliqua To Focus On Development, Manufacturing And Marketing Of Proprietary Transdermal Drug Delivery Products 120
11.1.2 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units 121
11.1.3 Aug 31, 2010: Vetter Opens New Sales Office At Illinois Science + Technology Park In Suburban Chicago 122
11.1.4 Aug 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey 122
11.1.5 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring 123
11.1.6 Jul 14, 2010: GE Healthcare To Shut Down Two Offices In Waukesha 123
11.1.7 Jul 01, 2010: Shionogi Announces Reorganization Of US Operations 123
11.1.8 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 124
11.2 Legal and Regulatory 124
11.2.1 Mar 16, 2011: Tekmira Sues Alnylam Pharmaceuticals For Repeated Misuse Of Trade Secrets And Confidential Information 124
11.2.2 Feb 11, 2011: University Of Florida Research Foundation Initiates Court Case Against Diamyd Medical 125
11.2.3 Nov 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter 125
11.2.4 Nov 09, 2010: Greenberg Traurig And Segal McCambridge Singer & MahoneyObtain Three Defense Verdicts For I-Flow In Oregon Infusion Pump Cases 126
11.2.5 Nov 03, 2010: Protein Sciences Reports Settlement With Emergent BioSolutions 126
11.2.6 Sep 03, 2010: BioSphere Agrees To Settle Suit Over Merit Medical merger 126
11.2.7 Jul 30, 2010: Federal Appeals Court Rules In Favor Of Covidien In Needle Patents Suit 126
11.2.8 Jul 23, 2010: BioSphere Names In Class Action By Shareholders: SEC Filing 127
11.2.9 Jun 10, 2010: I-Flow Resolves Patent Infringement, Trade Secret Litigation Against Apex Medical Technologies, Zone Medical 127
11.3 Government and Public Interest 127
11.3.1 Mar 16, 2011: Syracuse University Scientists Develop New Drug Delivery System To Improve Cancer Treatment 127
11.3.2 Feb 17, 2011: Delcath Achieves ISO 13485 Certification 128
11.3.3 Dec 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design 129
11.3.4 Oct 26, 2010: GERES Study Confirms Passive Safety Devices Are Most Effective In Needlestick Injury Prevention 129
11.3.5 Aug 31, 2010: Purdue University Researchers Develop New Pump For Microneedle Drug-Delivery Patch 130
11.3.6 Aug 09, 2010: Talecris Biotherapeutics And Grifols Receive FTC Request For Additional Information Regarding Proposed Merger 131
11.3.7 Jun 14, 2010: Electronic Cigarettes Are Drug Delivery Devices And Should Be Subject To FDA Regulations: AMA 132
11.4 Product News 132
11.4.1 Jul 27, 2010: Dentistry Today Selects Milestone's STA Single Tooth Anesthesia System For Top 100 Products Award Program 132
11.4.2 Jul 13, 2010: Baxter Announces Final Details Regarding Previously Communicated COLLEAGUE Infusion Pump Recall In US 133
11.4.3 Jul 08, 2010: Bioject Announces Use Of Its Intradermal Needle-Free Delivery System In World Health Organization Clinical Trial In Oman With Poliovirus Vaccine 134
12 Appendix 135
12.1 Definitions of Markets Covered in the Report 136
12.1.1 Drug Delivery Devices 136
12.2 Research Methodology 138
12.3 Secondary Research 139
12.4 Primary Research 139
12.5 Models 140
12.6 Forecasts 140
12.7 Expert Panels 140
12.8 GlobalData Consulting 140
12.9 Currency Conversion 141
12.10 Contact Us 141
12.11 Disclaimer 141
1.1 List of Tables
Table 1: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 15
Table 2: Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17
Table 3: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017 18
Table 4: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010 20
Table 5: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 22
Table 6: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23
Table 7: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010 25
Table 8: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017 27
Table 9: Drug Delivery Devices, United States, Company Share by Revenue ($m), 2009-2010 29
Table 10: Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32
Table 11: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010 34
Table 12: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017 36
Table 13: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010 38
Table 14: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017 40
Table 15: Central Venous Catheters, United States, Average Price ($), Historic, 2003-2010 41
Table 16: Central Venous Catheters, United States, Average Price ($), Forecast, 2010-2017 41
Table 17: Central Venous Catheters, United States, Distribution Share by Revenue ($m), 2009-2010 42
Table 18: Central Venous Catheters, United States, Company Share by Revenue ($m), 2009-2010 44
Table 19: Infusion Systems Market, United States, Segment Contribution (%), 2010 47
Table 20: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010 49
Table 21: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017 51
Table 22: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 53
Table 23: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 55
Table 24: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 57
Table 25: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 59
Table 26: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010 61
Table 27: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017 63
Table 28: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Table 29: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Table 30: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Table 31: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Table 32: Infusion Systems, United States, Average Price ($), Historic, 2003-2010 70
Table 33: Infusion Systems, United States, Average Price ($), Forecast, 2010-2017 70
Table 34: Infusion Systems, United States, Distribution Share by Revenue ($m), 2009-2010 71
Table 35: Infusion Systems, United States, Company Share by Revenue ($m), 2009-2010 73
Table 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010 74
Table 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017 75
Table 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010 76
Table 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017 77
Table 40: Metered Dose Inhaler Devices, United States, Average Price ($), Historic, 2003-2010 78
Table 41: Metered Dose Inhaler Devices, United States, Average Price ($), Forecast, 2010-2017 78
Table 42: Metered Dose Inhaler Devices, United States, Distribution Share by Revenue ($m), 2009-2010 79
Table 43: Metered Dose Inhaler Devices, United States, Company Share by Revenue ($m), 2009-2010 81
Table 44: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010 82
Table 45: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017 83
Table 46: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010 84
Table 47: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017 85
Table 48: Needle Free Injections, United States, Average Price ($), Historic, 2003-2010 86
Table 49: Needle Free Injections, United States, Average Price ($), Forecast, 2010-2017 86
Table 50: Needle Free Injections, United States, Distribution Share by Revenue ($m), 2009-2010 87
Table 51: Needle Free Injections, United States, Company Share by Revenue ($m), 2009-2010 89
Table 52: Drug Delivery Devices Market Pipeline Products 101
Table 53: CarePoint Partners Acquires Premier Infusion 108
Table 54: SurModics Plans The Sale Of SurModics Pharmaceuticals 109
Table 55: BTG International To Acquire Biocompatibles 110
Table 56: Nordson Completes Acquisition Of Micromedics 112
Table 57: Cardinal Health Sells 13.7% Stake In Carefusion 113
Table 58: Cellectis Acquires Cyto Pulse Sciences 114
Table 59: Eli Lilly Enters Into Collaboration With Medtronic 115
Table 60: West Pharmaceutical Enters Into Agreement With CareFusion 116
Table 61: Nile Therapeutics Enters Into An Agreement With Medtronic 117
Table 62: Hospira Enters Into An Agreement With Smiths Medical 118
Table 63: AorTech International Enters Into Technology License Agreement 119
Table 64: USD to Local Currency, United States, Average Actual Rate 2003-2010 141
1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 13
Figure 2: Drug Delivery Devices, United States, Overall Revenue ($m), 2003-2017 14
Figure 3: Drug Delivery Devices Market, United States, Revenue Mix ($m), 2010 16
Figure 4: Drug Delivery Devices Market, United States, Category Contribution (%), 2010 17
Figure 5: Drug Delivery Devices, United States, Cross-Category Analysis, 2003-2017 18
Figure 6: Drug Delivery Devices, United States, Overall Revenue ($m), Historic, 2003-2010 19
Figure 7: Drug Delivery Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 21
Figure 8: Drug Delivery Devices, United States, Category Volume (Units), 2003-2017 23
Figure 9: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2003-2010 24
Figure 10: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2010-2017 26
Figure 11: Drug Delivery Devices, United States, Company Share (%), 2010 28
Figure 12: Central Venous Catheters, Market Segmentation 30
Figure 13: Central Venous Catheters Market, United States, Revenue Mix ($m), 2010 31
Figure 14: Central Venous Catheters Market, United States, Segment Contribution (%), 2010 32
Figure 15: Central Venous Catheters, United States, Revenue ($m) by Segment, Historic, 2003-2010 33
Figure 16: Central Venous Catheters, United States, Revenue ($m) by Segment, Forecast, 2010-2017 35
Figure 17: Central Venous Catheters, United States, Volume (Units) by Segment, Historic, 2003-2010 37
Figure 18: Central Venous Catheters, United States, Volume (Units) by Segment, Forecast, 2010-2017 39
Figure 19: Central Venous Catheters, United States, Company Share (%), 2010 43
Figure 20: Infusion Systems, Market Segmentation 45
Figure 21: Infusion Systems Market, United States, Revenue Mix ($m), 2010 46
Figure 22: Infusion Systems Market, United States, Segment Contribution (%), 2010 47
Figure 23: Infusion Systems, United States, Revenue ($m) by Segment, Historic, 2003-2010 48
Figure 24: Infusion Systems, United States, Revenue ($m) by Segment, Forecast, 2010-2017 50
Figure 25: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52
Figure 26: Syringe Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54
Figure 27: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Figure 28: Ambulatory Infusion Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Figure 29: Infusion Systems, United States, Volume (Units) by Segment, Historic, 2003-2010 60
Figure 30: Infusion Systems, United States, Volume (Units) by Segment, Forecast, 2010-2017 62
Figure 31: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Figure 32: Syringe Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Figure 33: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Figure 34: Ambulatory Infusion Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Figure 35: Infusion Systems, United States, Company Share (%), 2010 72
Figure 36: Metered Dose Inhaler Devices, United States, Revenue ($m) Historic, 2003-2010 74
Figure 37: Metered Dose Inhaler Devices, United States, Revenue ($m) Forecast, 2010-2017 75
Figure 38: Metered Dose Inhaler Devices, United States, Volume (Units) Historic, 2003-2010 76
Figure 39: Metered Dose Inhaler Devices, United States, Volume (Units) Forecast, 2010-2017 77
Figure 40: Metered Dose Inhaler Devices, United States, Company Share (%), 2010 80
Figure 41: Needle Free Injections, United States, Revenue ($m) Historic, 2003-2010 82
Figure 42: Needle Free Injections, United States, Revenue ($m) Forecast, 2010-2017 83
Figure 43: Needle Free Injections, United States, Volume (Units) Historic, 2003-2010 84
Figure 44: Needle Free Injections, United States, Volume (Units) Forecast, 2010-2017 85
Figure 45: Needle Free Injections, United States, Company Share (%), 2010 88
Figure 46: GlaxoSmithKline plc, Company Share (%),United States Drug Delivery Devices Market, 2010 90
Figure 47: Hospira, Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 91
Figure 48: CareFusion Corporation, Company Share (%),United States Drug Delivery Devices Market, 2010 92
Figure 49: Boehringer Ingelheim GmbH, Company Share (%),United States Drug Delivery Devices Market, 2010 93
Figure 50: AstraZeneca PLC, Company Share (%),United States Drug Delivery Devices Market, 2010 94
Figure 51: Baxter International Inc., Company Share (%),United States Drug Delivery Devices Market, 2010 95
Companies MentionedGlaxoSmithKline plc
Hospira, Inc.
CareFusion Corporation
Boehringer Ingelheim GmbH
AstraZeneca PLC
Baxter International Inc.
Medtronic, Inc.
Teleflex Incorporated
Smiths Medical
Fresenius Kabi AG
B. Braun Melsungen AG
Terumo Corporation
Consort Medical plc
3M Health Care
Edwards Lifesciences Corporation
Becton, Dickinson and Company
Cook Medical Incorporated
INJEX - Equidyne Systems
Antares Pharma, Inc.
Bioject Medical Technologies Inc.
To order this report:
Drug Delivery Technology Industry: Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Drug Delivery Technology Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
CONTACTNicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker